Phage-therapy is a promising alternative against pathogenic, multiple drug resistant bacteria. In this work we propose an algorithm to determine the optimal bacteriophage dose able to minimize a population of Pseudomonas aeruginosa. Reverse engineering was used to determine the kinetic parameters; subsequently, a bi-level optimization platform was implemented for a model based on evolutionary programming. Our prediction of optimal dose was tested in vitro with planktonic cultures of P. aeruginosa. From the data obtained, we conclude that reverse engineering and stochastic simulations are a useful approach to find optimal phage doses against pathogenic bacteria, an important step for the implementation of phage-therapy. 19 ABSTRACT 20 Phage-therapy is a promising alternative against pathogenic, multiple drug resistant bacteria. In 21 this work we propose an algorithm to determine the optimal bacteriophage dose able to minimize 22 a population of Pseudomonas aeruginosa. Reverse engineering was used to determine the kinetic 23 parameters; subsequently, a bi-level optimization platform was implemented for a model based 24 on evolutionary programming. Our prediction of optimal dose was tested in vitro with planktonic 25 cultures of P. aeruginosa. From the data obtained, we conclude that reverse engineering and 26 stochastic simulations are a useful approach to find optimal phage doses against pathogenic 27 bacteria, an important step for the implementation of phage-therapy. 
INTRODUCTION
The treatment of intra-hospital infections (nosocomial infections) has turned out to be an 40 enormous challenge as the current microorganisms display high capability to resist multiple 41 varieties of antibiotics. A number of bacterial resistance mechanisms against antibiotics exist 43 from biofilm assembly, [1] active site mutations where an antibiotic is no longer capable of 44 binding to the cell wall and toxic molecule ejection through efflux pumps and transmembrane 45 proteins, [2] among others. 46 Hospitals and more specifically Intensive Care Units are generally considered epicenters of 47 antibiotic resistance and the principal sources of outbreaks of multiple drug-resistant bacteria. [3] 48 For this reason, biomedical communities have been urged to investigate new anti-bacterial 49 treatments such as the next generation drugs and therapies with improved spectrums against 50 resistant microorganisms. [4] Approaches based on bacteriophages (or phages), known as phage- 51 therapy, constitute an interesting alternative due to the ease of isolating phages capable of 52 targeting antibiotic resistant bacteria. Also, viruses evolve with their host allowing them to infect 53 phage-resistant cells when they would appear. Regarding the diffusional obstacles, antibiotics in 54 general have to overcome several hurdles due to the presence of exopolysaccharides when the 55 biofilm phenotype is present; phages, on the other hand, are in theory capable of efficiently 56 penetrating the biofilm so the infection would be deeply inhibited. [5] The mechanism exploited in 57 phage therapy is the obligatorily lytic life cycle when the viral particles recognize the bacterial 58 cell surface, followed by reversible and irreversible binding and the injection of its DNA or RNA 59 from phage capsid into the host. Once the phage genome has shut down, most of the host's 60 proteins are amplified inside the cell using its host's molecular machinery and consequently viral 61 progeny are formed. Finally, cell lysis occurs resulting in progeny exiting the cell and repeating a 62 new infective cycle. [6] P. aeruginosa is one of the principal causes of acquired infections and 63 mortality in hospitals. [7] This microorganism is highly adaptive, considered an opportunist 66 anatomical sites such as the upper respiratory tract, lungs, heart valves, urinary tract, surgical 67 tract and open wounds. [7] 68 The advent of mathematical biology has allowed a greater understanding of the underpinnings of 69 several biological events with important applications for disease control. In order to get a better 70 comprehension of the dynamics of the infection process deterministic and stochastic modeling 71 was applied to predict the behavior of the phages infecting a planktonic population of several 72 bacterial species. [9] [10] [11] [12] Deterministic approaches are commonly used and assume that the species 73 in the system change continuously and deterministically over time and are based on ordinary 74 differential equations (ODES). These models describe the dynamics of the system in terms of the 75 species present, and parameters related with the rates of change in the concentration of these 76 species. [12] From this approximation, it's possible to make an evaluation of the parameters that 77 have an influence on the rate of the infective process (kinetic parameters). Stochastic models are 78 based on random collisions among reacting species, making them useful to simulate or predict 79 events in biological systems such as metabolic regulation systems and genetic networks. The 80 stochastic approach allows modeling phage-host infection in which the effects of noise, 81 variations, and uncertainty are reflected in the system dynamics. [13] 82
Once the dynamics of the infection are understood, the search space or feasible region can be 83 predicted to find the optimum therapeutic dose that would allow for controlling the pathogen and 84 mitigate the occurrence of phage-resistance. [14] To do so, it's necessary to establish an 85 optimization algorithm with an efficient searching capacity, satisfactory robustness and low 86 computational demand. Our group has prior experience with using Monte Carlo-based 89 optimization, most of stochastic methods are not gradient based so either stochastic or 90 deterministic models can be used as a template to find the optimum. 91 Different authors have studied the bacteriophage-host dynamics from only one or the other of the 92 two approaches. Cairns et al. studied Campylobacter and bacteriophage interactions using a 93 kinetic model based on ODES.
[16] Jain et al used five different deterministic models to evaluate 94 the infection dynamics of phage MS2 in its host Escherichia coli. [12] Arkin et al used a stochastic 95 kinetic analysis to investigate the mechanism that causes the lysis-lysogeny decision circuit of 96 phage λ in E. coli. [10] In a more recent study, Bardina et al made a stochastic formulation to study 97 bacteriophage treatments for infections. [17] All these works have been made to understand the 98 dynamics of phage-bacteria systems and calculate the parameters that affect the specific case of 99 study. 100 Here in this study we proposed and applied an optimization platform, based on deterministic and 101 stochastic-derived models built from previous experimental data to find the optimal dosage able 102 to diminish a P. aeruginosa population. The experimental validation of the predicted dose was 103 performed in three different ways: First, elucidating the behavior in vitro of the infection process. 104 Second, evaluating the extrapolable characteristic of the dose to other phage-bacteria systems. 105 And third, corroborating the optimal value of the dose performing a challenge test. 264 Simulated annealing and genetic algorithms were used to perform the parametric regression from 265 experimental data with an estimated phage dose of 1x10 5 PFU/cm 3 using the System biology 266 toolbox in Matlab ® . [18] Finally the three individual models that best described each system in 267 vitro (P. aeruginosa P1, P3 and P4 infected with phage F1) were merged to create a petri net 268 capable of describing the infection dynamics of F1 infecting these three strains in unison (Fig. 1 The predicted dose was experimentally validated in vitro in order to test the accuracy of the 311 computational models. To achieve this, each strain was grown in MSM to logarithmic phase, 312 established by the deterministic models: P. aeruginosa P1 was grown up to 10 9 CFU/cm 3 , P.
313 aeruginosa P3 up to 10 8 CFU/cm 3 , P. aeruginosa P4 up to 10 6 CFU/cm 3 . At the desired cell 314 density, each bacteriophage was added, separately, at a concentration of 10 7 PFU/cm 3 . The 315 cultures were monitored for 1100 minutes where optical density and bacterial survivors were 316 measured. 317 Additional tests were also performed with the P4 strain and the phage F1 to assess the potential 318 difference in kinetics with varied phage doses above and below the optimal dose. P4 was grown 321 monitored for 1100 min and optical densities and bacterial survivors were measured. 322 All the experiments explained in this section were carried out in triplicate. 323 324 325
RESULTS AND ANALYSIS

327
3.1. Phage-strain individual models 328 329 Models 1 through 6 were tested against experimental data using least squares sum, to determine 330 which assumptions described the dynamics best (Table 1) . Interestingly, we found kinetic 331 parameters and model fitness were dependent on the strain analyzed. For P. aeruginosa P1 and 332 P3 infected with phage F1, the model that best described the infection process was Model 6. , 333 Model 2 best described the infection process of P. aeruginosa P4 infected with phage F1 334 however. This is likely because P. aeruginosa P1 and P3 uninfected cells grew at different rates 335 (infected cells had a different growth rate since the number of infected cells is calculated as the 336 total cell population minus the uninfected cells), and a decline in the population of uninfected 337 cells of P. aeruginosa P4 wasn't observed (Fig. 2) , meaning infected cells weren't as prevalent. 338 Model selection and parameterization is strongly influenced by the strain due to differences in 339 interaction dynamics, the mechanisms of infection and/or bacterial resistance to phage F1. 340 According to our data, P4 continues to grow as an uninfected culture, indicating that this strain 341 had weaker respond to phage F1 (Fig. 2) . We believe that this difference is based on dissimilar 342 adsorption rates and parameters, DNA injection, DNA replication, progeny assembly, among 343 others, which were not taken into account in this case. We observed that the infection process is 344 also dependent on the length of the eclipse phase, which suggested that it was dependent on the 348 grow. 349 In Table 2 the kinetic parameters for each system shown in accordance with the model that best 350 fit. These parameters were used later to feed the model for optimal dose calculations. 351 Additionally an indentifiability analysis of all six models was made using GenSSI, a Matlab 352 toolbox for studying structural identifiability using iterative lie derivatives and identifiability 353 tableaus. [19] With this analysis we could determine that models 1, 2, 3, 4, and 6 are globally 365 caused by any one of the three strains. Genetic algorithm parameters were heuristically 366 determined using a gene probability of 0.5 and a tolerance of 0.001. We initially obtained the 367 model for each strain in order to elucidate the mechanism without considering the possible 368 interactions among strains. Then, we fused them together and proposed a Petri net that represents 370 equations, which relate the initial population for each strain, the initial phage dose, and the length 371 of infection. The differential equation system was used to feed kinetic parameters previously 372 found and was coupled with the genetics algorithm platform and the optimal dose was evaluated. 373 With a treatment time of 1,100 min the genetic algorithm predicted an optimal dose for the phage 374 concentration of 6.50 × 10 7 PFU/cm 3 . Numerical integration of the ordinary differential 375 equations using the Runge Kutta fourth order method predicts that the bacterial survivors of P.
376 aeruginosa P1 would decrease from 1.2×10 5 to 8.4 ×10 2 CFU/ cm 3 , P. aeruginosa P3 from 5 × 377 10 8 CFU/cm 3 to 2 × 10 3 CFU/cm 3 , P. aeruginosa P4 from 9 ×10 6 CFU/cm 3 to 3×10 3 CFU/cm 3 378 (results not shown). The mixed population model (P1, P3, and P4) would be reduced from 1.4 × 379 10 9 CFU/cm 3 to 2.16 × 10 5 CFU/cm 3 (Fig. 3) . (Fig. 4) . Interestingly, we 393 viral inoculation should take place in early stages, similar to a prophylactic application, in order 394 to avoid dispersion of the bacteria. The early presence of the phage would also lower the phage 395 dose needed to eliminate the pathogen. 396 397 3.4. Phage dose experimental validation 398 In order to elucidate the behavior of the system in vitro using the optimum phage dose predicted 399 infection curves were assayed. P. aeruginosa P1, P3, and P4 strains were grown as explained 400 before and phage F1 was added in the optimum dose in early stages of bacterium growth based 401 on our stochastic predictions. 
